10x Genomics, Inc. (TXG)

10x Genomics Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for 10x Genomics stock have an average target of 23.79, with a low estimate of 14 and a high estimate of 35. The average target predicts an increase of 101.27% from the current stock price of 11.82.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$14	$23.79	$25	$35
Change	+18.44%	+101.27%	+111.51%	+196.11%

Analyst Ratings

The average analyst rating for 10x Genomics stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	3	4	4	4	4	4
Buy	4	4	4	4	4	4
Hold	7	7	7	7	7	7
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	15	16	16	16	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Luke Sergott Barclays	Barclays	Buy Maintains $19 → $18	Buy	Maintains	$19 → $18	+52.28%	Feb 10, 2025
Tejas Savant Morgan Stanley	Morgan Stanley	Buy Maintains $30 → $28	Buy	Maintains	$30 → $28	+136.89%	Jan 13, 2025
Luke Sergott Barclays	Barclays	Buy Maintains $21 → $19	Buy	Maintains	$21 → $19	+60.74%	Nov 1, 2024
Patrick Donnelly Citigroup	Citigroup	Strong Buy Maintains $35 → $23	Strong Buy	Maintains	$35 → $23	+94.59%	Oct 30, 2024
Matthew Sykes Goldman Sachs	Goldman Sachs	Strong Sell Maintains $16 → $14	Strong Sell	Maintains	$16 → $14	+18.44%	Oct 30, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

610.63M

Decreased by -1.31%

from 618.73M

Revenue Next Year

637.51M

Increased by 4.40%

from 610.63M

EPS This Year

-1.43

from -2.18

EPS Next Year

-1.29

from -1.43

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	245.89M	298.85M	490.49M	516.41M	618.73M	610.63M	637.51M	695.40M
Revenue Growth	68.06%	21.53%	64.13%	5.28%	19.81%	-1.31%	4.40%	9.08%
EPS	-0.80	-5.37	-0.53	-1.46	-2.18	-1.43	-1.29	-0.92
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	20	20	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028	2029
High	641.3M	695.0M	756.3M
Avg	610.6M	637.5M	695.4M
Low	585.8M	592.5M	633.5M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028	2029
High	3.7%	13.8%	18.6%
Avg	-1.3%	4.4%	9.1%
Low	-5.3%	-3.0%	-0.6%

EPS Forecast

EPS	2024	2025	2026	2027	2028	2029
High	-1.32	-0.90	-0.04
Avg	-1.43	-1.29	-0.92
Low	-1.46	-1.52	-1.49

EPS Growth

EPS Growth	2024	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.